In This Article:
NEW YORK, NY / ACCESSWIRE / August 3, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.
J2 Global, Inc. (NASDAQ:JCOM)
CONTACT JAKUBOWITZ ABOUT JCOM:
https://claimyourloss.com/securities/j2-global-inc-loss-submission-form/?id=8342&from=1
Class Period : October 5, 2015 - June 29, 2020
Lead Plaintiff Deadline : September 8, 2020
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) J2 Global engaged in undisclosed related party transactions; (2) J2 Global used misleading accounting to hide requisite impairments and underperformance in acquisitions; (3) several so-called independent members of the Company' board of directors and audit committee were not disinterested; and (4) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.
Bayer Aktiengesellschaft (OTC PINK:BAYRY)
CONTACT JAKUBOWITZ ABOUT BAYRY:
https://claimyourloss.com/securities/bayer-aktiengesellschaft-loss-submission-form/?id=8342&from=1
Lawsuit on behalf of all persons or entities that purchased or otherwise acquired Bayer American Depositary Receipts between May 23, 2016 and March 19, 2019.
Lead Plaintiff Deadline : September 14, 2020
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: 1) following its acquisition of Monsanto Company, Bayer could be at risk of suffering billions of dollars in judgments and reputational damage if the lawsuits brought against Monsanto alleging that exposure to its glyphosate-based Roundup product caused cancer were successful, 2) a result, Defendants' positive statements about the prospects of the Monsanto acquisition and the benefits it would create for Bayer's business were materially false and/or misleading and/or lacked a reasonable basis.
Velocity Financial, Inc. (NYSE:VEL)
CONTACT JAKUBOWITZ ABOUT VEL:
https://claimyourloss.com/securities/velocity-financial-inc-loss-submission-form/?id=8342&from=1
This lawsuit is on behalf of investors who purchased VEL stocks pursuant and/or traceable to the Registration Statement and Prospectus, as amended, issued in connection with Velocity's January 2020 initial public offering.
Lead Plaintiff Deadline : September 28, 2020